US$ 26.32
bpc-157 typical cycle length days weeks Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 vs TB-500: Complete Comparison
Description
Risk Factors & At-Risk Groups

Betnesol is a prescription injection given by doctors in a hospital setting

It acts as an antioxidant
Appearance: Freeze-dried powder
Try water aerobics alongside swimming see below for ideas
